-
CNW Group via Yahoo! Finance - Wed Nov 18, 8:30 am ET
Medicago Inc. , a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles , today announced that Frederic Ors, VP Business Development will be presenting at the Influenza Congress USA 2009 on November 20, 2009 at 11:00 am at The Westin Washington, Washington, D.C.
-
PR Newswire via Yahoo! Finance - Wed Nov 18, 8:29 am ET
Sinovac Biotech Ltd. , a leading developer and provider of vaccines, announced today that it has filed a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission.
-
Business Wire via Yahoo! Finance - Wed Nov 18, 3:30 am ET
AUSTIN, Texas----Asuragen, Inc. announced today that it has entered into an exclusive agreement with Life Technologies Corporation to develop and distribute worldwide an in-vitro diagnostic test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia .
-
Bloomberg - Mon Nov 16, 11:56 pm ET
Nov. 17 (Bloomberg) -- China and the World Health Organization agreed to open an influenza research center in Beijing to identify and share knowledge about new strains.
-
Department of Homeland Security - Tue Nov 17, 2:46 pm ET
Testimony of Alex Garza, MD, MPH, Assistant Secretary for Health Affairs and Chief Medical Officer, Office of Health Affairs, before the Senate Homeland Security and Governmental Affairs Committee on "H1N1 Flu: Getting the Vaccine to Where it is Most Needed"
-
PR Newswire via Yahoo! Finance - Tue Nov 17, 11:25 am ET
Sinovac Biotech Ltd. , a leading developer and provider of vaccines in China, announced today that it received a revised production license from State Food and Drug Administration for Panflu.1, the Company's H1N1 vaccine.
-
Business Wire via Yahoo! Finance - Tue Nov 17, 4:28 am ET
DUBLIN----Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009" to their offering.
-
Pasadena Weekly - Mon Nov 16, 2:53 pm ET
Flight Paths of Death
-
redOrbit - Sun Nov 15, 10:07 pm ET
BEIJING, Nov. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines, announced today that it was selected by the Shanghai Government to supply its inactivated hepatitis A vaccine, Healive, to the public market of Shanghai.
-
Bloomberg - Tue Dec 15, 2:30 am ET
Dec. 15 (Bloomberg) -- Swine flu may crimp Australia’s gross domestic product by 0.5 percent this year and cease to affect the economy in 2010, economists in Melbourne said.
-
EurekAlert! - Sun Dec 6, 1:21 pm ET
( American Society for Cell Biology ) A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1 (avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies.
-
Science News - Wed Dec 9, 10:53 am ET
Computer screening reveals possible drugs the H1N1 and H5N1 flu viruses just wouldn’t be able to resist
-
Science News - Tue Dec 8, 3:23 pm ET
Computer screening reveals possible drugs the H1N1 and H5N1 flu viruses just wouldn’t be able to resist
-
Bloomberg - Tue Dec 8, 8:09 am ET
Dec. 8 (Bloomberg) -- Flu vaccine shortages in developing nations may destabilize global security should the H1N1 virus become more deadly, said David Heymann , a former deputy head of the World Health Organization.
-
Bloomberg - Tue Nov 24, 12:49 am ET
Nov. 24 (Bloomberg) -- A fresh wave of bird flu outbreaks in Egypt, Indonesia, Vietnam and Thailand highlights the threat to public health caused by the H5N1 virus, which risks swapping genes with other influenza strains to spawn new variants, the World Health Organization in Manila said in a statement today.
